Anika Therapeutics (ANIK) Tax Provisions (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Tax Provisions of $100000.0 for Q2 2026, down 85.71% year-over-year from $700000.0 in Q2 2025, and down 57.45% quarter-over-quarter from $235000.0 in Q1 2026.
Anika Therapeutics (ANIK) Tax Provisions (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Tax Provisions for 17 consecutive years, with $100000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Tax Provisions fell 85.71% year-over-year to $100000.0; the TTM figure through Jun 2026 stood at -$2.4 million (down 143.24% YoY), while the FY2025 annual figure was -$2.0 million, down 132.22% from the prior year.
- Tax Provisions slipped to $100000.0 in Q2 2026 per ANIK's latest filing, from $235000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $9.1 million in Q4 2023 and bottomed at -$3.7 million in Q4 2025.
- Historically, Tax Provisions has averaged $846555.6 across 5 years, with a median of $100000.0 in 2025.
- Annual changes were most pronounced in 2022 — Tax Provisions tumbled 271.43% — and 2024, when it surged 540.0%.
- Anika Therapeutics' Tax Provisions stood at $6.6 million in 2022, then soared by 37.62% to $9.1 million in 2023, then sank by 72.24% to $2.5 million in 2024, then tumbled by 245.07% to -$3.7 million in 2025, then soared by 102.73% to $100000.0 in 2026.
- Business Quant data shows ANIK's Tax Provisions at $100000.0 in Q2 2026, $235000.0 in Q1 2026, and -$3.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Anika Therapeutics | 285.40 Mn | 246.98 Mn | 21.24 Mn | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100,000.00 |
| Mar 31, 2026 | 235,000.00 |
| Dec 31, 2025 | -3.66 Mn |
| Sep 30, 2025 | 939,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 2.53 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 43,000.00 |
| Dec 31, 2023 | 9.10 Mn |
| Sep 30, 2023 | -500,000.00 |
| Jun 30, 2023 | -329,000.00 |
| Mar 31, 2023 | -1.70 Mn |
| Dec 31, 2022 | 6.61 Mn |
| Sep 30, 2022 | -1.20 Mn |
| Jun 30, 2022 | -442,000.00 |
| Mar 31, 2022 | -800,000.00 |
| Dec 31, 2021 | -3.41 Mn |
| Sep 30, 2021 | 700,000.00 |